↓ Skip to main content

The future of viral hepatitis testing: innovations in testing technologies and approaches

Overview of attention for article published in BMC Infectious Diseases, November 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
policy
2 policy sources
twitter
22 X users

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
180 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The future of viral hepatitis testing: innovations in testing technologies and approaches
Published in
BMC Infectious Diseases, November 2017
DOI 10.1186/s12879-017-2775-0
Pubmed ID
Authors

Rosanna W. Peeling, Debrah I. Boeras, Francesco Marinucci, Philippa Easterbrook

Abstract

A large burden of undiagnosed hepatitis virus cases remains globally. Despite the 257 million people living with chronic hepatitis B virus infection, and 71 million with chronic viraemic HCV infection, most people with hepatitis remain unaware of their infection. Advances in rapid detection technology have created new opportunities for enhancing access to testing and care, as well as monitoring of treatment. This article examines a range of other technological innovations that can be leveraged to provide more affordable and simplified approaches to testing for HBV and HCV infection and monitoring of treatment response. These include improved access to testing through alternative sampling methods (use of dried blood spots, oral fluids, self-testing) and combination rapid diagnostic tests for detection of HIV, HBV and HCV infection; more affordable options for confirmation of virological infection (HBV DNA and HCV RNA) such as point-of-care molecular assays, HCV core antigen and multi-disease polyvalent molecular platforms that make use of existing centralised laboratory based or decentralised TB and HIV instrumentation for viral hepatitis testing; and finally health system improvements such as integration of laboratory services for procurement and sample transportation and enhanced data connectivity to support quality assurance and supply chain management.

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 180 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 17%
Student > Ph. D. Student 17 9%
Student > Master 15 8%
Student > Bachelor 15 8%
Other 14 8%
Other 29 16%
Unknown 60 33%
Readers by discipline Count As %
Medicine and Dentistry 30 17%
Biochemistry, Genetics and Molecular Biology 13 7%
Immunology and Microbiology 11 6%
Agricultural and Biological Sciences 10 6%
Nursing and Health Professions 9 5%
Other 34 19%
Unknown 73 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#1,306,985
of 25,257,066 outputs
Outputs from BMC Infectious Diseases
#310
of 8,517 outputs
Outputs of similar age
#26,469
of 336,295 outputs
Outputs of similar age from BMC Infectious Diseases
#4
of 135 outputs
Altmetric has tracked 25,257,066 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,517 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,295 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 135 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.